Request appointment
325 W 15th StNew York, NY 10011
Fax+1 212-604-6038
Overview of Dr. Klein
Dr. Paula Klein is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 40 years. Dr. Klein accepts several types of health insurance, listed below. She is one of 121 doctors at Mount Sinai Beth Israel and one of 81 doctors at Mount Sinai Morningside who specialize in Oncology. She has more than 20 publications and over 500 citings.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1998- NYU Grossman School of MedicineResidency, Internal Medicine, 1986 - 1989
- NYU Grossman School of MedicineInternship, Internal Medicine, 1986 - 1987
State University of New York Downstate Medical Center College of MedicineClass of 1986
Certifications & Licensure
NY State Medical License 1987 - 2028
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2016
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2016
- Top Doctors: New York Metro Area Castle Connolly, 2014
Clinical Trials
- Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 Sep 24
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 Jul 21
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 2011 Jan 07
Publications & Presentations
PubMed
- A multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab, and pertuzumab in hormone receptor (HR)-positive, HER2-positive metastatic breast cancer (ASP...Rima Patel, Maryann Kwa, Paula Klein, Julie Fasano, Erin Moshier
Journal of the National Cancer Institute. 2026-07-30 - 1 citationsRandomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer.Rima Patel, Jami Fukui, Paula Klein, Erin Moshier, Hulya Kocyigit
Breast Cancer Research and Treatment. 2025-11-01 - 7 citationsA Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELE...Amy S Clark, Fengmin Zhao, Paula Klein, Alberto J Montero, Carla Falkson
Clinical Cancer Research. 2025-07-01
Press Mentions
Herceptin May Benefit Some Women with Early Breast CancerFebruary 6th, 2020
Long Haul for Breast Cancer Survivors: Disease Can Return After 20 YearsDecember 2nd, 2018
New Treatments Offer Hope for Advanced-Stage Breast Cancer PatientsAugust 28th, 2018
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPOHealth Alliance PPO
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: